top of page
Doctor Using Digital Tablet


Empowering Pharmaceutical Companies & CRO’s

Quickly and easily find the right U.S. clinical investigators to help complete clinical trials on-time


The ATRIA  Database


For Pharmaceutical Companies & CRO's

ATRIA is a clinical data repository containing a near census of all active trial investigators - categorized by specialty, experience, and performance - and of all U.S. clinical trials conducted since 2016. Using specialized performance-based database & analysis, ATRIA can:

Illustrated Laptop


  • ​Identify the most qualified potential investigators specific to the individual trial needs of Clinical Operations Teams and Clinical Study Managers

  • Provide performance scores calculated at a study level using the Leading Performance Metrics Algorithm (LPMA)

  • Use information about active U.S. clinical investigators and clinical sites through up-to-date, government-regulated data vetted by skilled professionals

Reduce cost of finding experienced investigators

Alleviate trial delays



Young Doctor

ATRIA Key Features:

On-demand, online database access

Designed for simplicity: easy to use, easy to explore

Pre-built reports and analysis

Create personal individual reports

Review of peers


ATRIA™ enables sponsor companies to find the most qualified US clinical investigators for clinical studies based on actual experience and performance data. The Sunshine Act requires that all payments by pharmaceutical companies to any US-based physician, as well as certain other medical professionals, be reported, classified, and verified by that physician. These payments clinical trial grants to both principal and sub-principal investigators.

We assessed these datasets to construct a near census of clinical trial activity by US-based clinical investigators since the latter half of 2014. The data is updated annually, with 2019 currently the most recent available.


With this data, it can be determined, for each clinical investigator:


  • ​On which clinical trials, and other related studies, the investigator has worked between 2014-2019, and;

  • For which sponsor company; and,

  • A physician’s medical specialty, address; and, vitally-

  • How the physician performed relative to others on each relevant clinical trial.


Proprietary data algorithms determine actual relative site patient enrollment performance. A majority of the data within ATRIA comes from Open Payments (Physical Payments Sunshine Act) and, enabling our approach for assessment of the site and investigator performance in the U.S. This produced two outcomes: a near census of investigator enrollment performance since 2014, and a summary of site experience and performance for all clinical trials conducted in the U.S. between 2014 - 2020.

bottom of page